Glutaminase, an enzyme that converts glutamine into glutamic acid, is overexpressed in breast cancer, especially in triple-negative breast cancer (TNBC) tumors compared with HER2 and luminal subtypes [52]. The gene discussed is ERBB2; the disease is breast carcinoma.